市場調査レポート

商品コード

中枢神経系（CNS）刺激薬の世界市場 2025～2029年

Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

出版日: 2025年02月07日
発行: TechNavio
ページ情報: 英文 214 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,150円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,240円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

中枢神経系（CNS）刺激薬市場は2024～2029年に86億10万米ドル、予測期間中のCAGRは6.7％で成長すると予測されます。

当レポートでは、中枢神経系（CNS）刺激薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、新規覚せい剤の承認、研究開発の拡大、企業による臨床検査の増加によって牽引されています。

市場範囲
基準年	2025年
終了年	2029年
予測期間	2025～2029年
成長モメンタム	加速
前年比[2025年]	6.4%
CAGR	6.7%
増分額	86億10万米ドル

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間における中枢神経系（CNS）刺激薬市場の成長を促進する主要要因の一つとして、新世代医薬品の取り込みの増加を挙げています。また、世界の大麻合法化需要の高まりや、医薬品の再利用の増加は、市場の大きな需要につながります。

中枢神経系（CNS）刺激薬の世界市場 2019～2023年
流通チャネル別セグメント分析 2019～2023年
用途別セグメント分析 2019～2023年
投与経路別セグメント分析 2019～2023年
地域別セグメント分析 2019～2023年
国別セグメント分析 2019～2023年

第6章定性分析

AIの影響：中枢神経系（CNS）刺激薬の世界市場

第7章ファイブフォース分析

ファイブフォースの要約
買い手の交渉力
供給企業の交渉力
新規参入業者の脅威
代替品の脅威
競争の脅威
市況

第8章市場セグメンテーション：流通チャネル別

市場セグメント
比較：流通チャネル別
病院：市場規模と予測 2024～2029年
その他：市場規模と予測 2024～2029年
市場機会：流通チャネル別

第9章市場セグメンテーション：用途別

市場セグメント
比較：用途別
注意欠陥多動性障害：市場規模と予測 2024～2029年
ナルコレプシー：市場規模と予測 2024～2029年
その他：市場規模と予測 2024～2029年
市場機会：用途別

第10章市場セグメンテーション：投与経路別

市場セグメント
比較：投与経路別
経口錠剤とカプセル：市場規模と予測 2024～2029年
注射剤：市場規模と予測 2024～2029年
経皮パッチ：市場規模と予測 2024～2029年
市場機会：投与経路別

第11章顧客情勢

顧客情勢概要

第12章地域別情勢

地域別セグメンテーション
比較：地域別
北米：市場規模と予測 2024～2029年
欧州：市場規模と予測 2024～2029年
アジア：市場規模と予測 2024～2029年
その他：市場規模と予測 2024～2029年
米国：市場規模と予測 2024～2029年
カナダ：市場規模と予測 2024～2029年
英国：市場規模と予測 2024～2029年
ドイツ：市場規模と予測 2024～2029年
メキシコ：市場規模と予測 2024～2029年
中国：市場規模と予測 2024～2029年
フランス：市場規模と予測 2024～2029年
日本：市場規模と予測 2024～2029年
インド：市場規模と予測 2024～2029年
イタリア：市場規模と予測 2024～2029年
地域情勢による市場機会

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場課題
促進要因と課題の影響
市場機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
産業のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Azurity Pharmaceuticals Inc.
Elite Pharmaceuticals Inc.
Hisamitsu Pharmaceutical Co. Inc.
Ironshore
Jazz Pharmaceuticals Plc
KemPharm Inc.
Merck and Co. Inc.
Novartis AG
Pfizer Inc.
Purdue Pharma LP
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Tris Pharma Inc.
Viatris Inc.

第16章付録

Product Code: IRTNTR72695

The central nervous system (CNS) stimulant drugs market is forecasted to grow by USD 8600.1 million during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by approval of new stimulants, growing research and development, and increasing clinical trials by companies.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.4%
CAGR	6.7%
Incremental Value	$8600.1 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's central nervous system (CNS) stimulant drugs market is segmented as below:

By Distribution Channel

Hospitals
Others

By Application

Attention-deficit hyperactivity disorder
Narcolepsy
Others

By Route Of Administration

Oral tablets and capsules
Injectables
Transdermal patches

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increased uptake of new-generation drugs as one of the prime reasons driving the central nervous system (CNS) stimulant drugs market growth during the next few years. Also, rising demand to legalize cannabis worldwide and increasing repurposing of drugs will lead to sizable demand in the market.

The report on the central nervous system (CNS) stimulant drugs market covers the following areas:

Central Nervous System (CNS) Stimulant Drugs Market sizing
Central Nervous System (CNS) Stimulant Drugs Market forecast
Central Nervous System (CNS) Stimulant Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading central nervous system (CNS) stimulant drugs market vendors that include Astellas Pharma Inc., Azurity Pharmaceuticals Inc., Elite Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Ironshore, Jazz Pharmaceuticals PLC, KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, Sanofi SA, SHIONOGI Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Tris Pharma Inc., and Viatris Inc.. Also, the central nervous system (CNS) stimulant drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Central Nervous System (CNS) Stimulant Drugs Market 2019 - 2023
- Historic Market Size - Data Table on Global Central Nervous System (CNS) Stimulant Drugs Market 2019 - 2023 ($ million)
5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Central Nervous System (CNS) Stimulant Drugs Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
8.4 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Application

9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
9.3 Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029
- Chart on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
- Data Table on Attention-deficit hyperactivity disorder - Market size and forecast 2024-2029 ($ million)
- Chart on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Attention-deficit hyperactivity disorder - Year-over-year growth 2024-2029 (%)
9.4 Narcolepsy - Market size and forecast 2024-2029
- Chart on Narcolepsy - Market size and forecast 2024-2029 ($ million)
- Data Table on Narcolepsy - Market size and forecast 2024-2029 ($ million)
- Chart on Narcolepsy - Year-over-year growth 2024-2029 (%)
- Data Table on Narcolepsy - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral tablets and capsules - Market size and forecast 2024-2029
- Chart on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral tablets and capsules - Market size and forecast 2024-2029 ($ million)
- Chart on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
- Data Table on Oral tablets and capsules - Year-over-year growth 2024-2029 (%)
10.4 Injectables - Market size and forecast 2024-2029
- Chart on Injectables - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
- Chart on Injectables - Year-over-year growth 2024-2029 (%)
- Data Table on Injectables - Year-over-year growth 2024-2029 (%)
10.5 Transdermal patches - Market size and forecast 2024-2029
- Chart on Transdermal patches - Market size and forecast 2024-2029 ($ million)
- Data Table on Transdermal patches - Market size and forecast 2024-2029 ($ million)
- Chart on Transdermal patches - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal patches - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
12.12 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Azurity Pharmaceuticals Inc.
- Azurity Pharmaceuticals Inc. - Overview
- Azurity Pharmaceuticals Inc. - Product / Service
- Azurity Pharmaceuticals Inc. - Key offerings
- SWOT
15.5 Elite Pharmaceuticals Inc.
- Elite Pharmaceuticals Inc. - Overview
- Elite Pharmaceuticals Inc. - Product / Service
- Elite Pharmaceuticals Inc. - Key offerings
- SWOT
15.6 Hisamitsu Pharmaceutical Co. Inc.
- Hisamitsu Pharmaceutical Co. Inc. - Overview
- Hisamitsu Pharmaceutical Co. Inc. - Key offerings
- SWOT
15.7 Ironshore
- Ironshore - Overview
- Ironshore - Product / Service
- Ironshore - Key offerings
- SWOT
15.8 Jazz Pharmaceuticals Plc
- Jazz Pharmaceuticals Plc - Overview
- Jazz Pharmaceuticals Plc - Product / Service
- Jazz Pharmaceuticals Plc - Key news
- Jazz Pharmaceuticals Plc - Key offerings
- SWOT
15.9 KemPharm Inc.
- KemPharm Inc. - Overview
- KemPharm Inc. - Key offerings
- SWOT
15.10 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.12 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.13 Purdue Pharma LP
- Purdue Pharma LP - Overview
- Purdue Pharma LP - Product / Service
- Purdue Pharma LP - Key offerings
- SWOT
15.14 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.15 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.16 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
15.17 Tris Pharma Inc.
- Tris Pharma Inc. - Overview
- Tris Pharma Inc. - Product / Service
- Tris Pharma Inc. - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

中枢神経系（CNS）刺激薬の世界市場 2025～2029年

Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：用途別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Application

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

中枢神経系（CNS）刺激薬の世界市場 2025～2029年

Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：流通チャネル別

第9章 市場セグメンテーション：用途別

第10章 市場セグメンテーション：投与経路別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Application

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：用途別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録